Both in Pharmaceuticals
IDEAYA Biosciences vs Amylyx Pharmaceuticals
Over the past year IDYA returned −0.1% and AMLX returned +100.0%; their daily moves had a correlation of 0.35.
IDYA −0.1% AMLX +100.0%Growth of $1, one year, split-adjusted
| Metric | IDYA | AMLX |
|---|---|---|
| Price | $33.16 | $28.64 |
| Market cap | $3.20B | $3.59B |
| Today | −2.36% | +2.01% |
| 1 month | −13.7% | −1.6% |
| 6 months | +14.0% | +79.0% |
| Year to date | −4.1% | +137.0% |
| 1 year | −0.1% | +100.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −1269.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.7× | — |
| Net cash | $829.0M | $250.8M |
| Dividend yield | — | — |
| Volatility (60d) | 36.7% | 114.5% |
| Short % of float | 10.4% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).